- Home
- VNRX vs HOWL Comparison
VNRX vs HOWL Comparison
Compare VNRX & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNRX
- HOWL
- Stock Information
- Founded
- VNRX N/A
- HOWL 2017
- Country
- VNRX United States
- HOWL United States
- Employees
- VNRX N/A
- HOWL N/A
- Industry
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- HOWL Biotechnology: Pharmaceutical Preparations
- Sector
- VNRX Health Care
- HOWL Health Care
- Exchange
- VNRX Nasdaq
- HOWL Nasdaq
- Market Cap
- VNRX 52.4M
- HOWL 47.1M
- IPO Year
- VNRX N/A
- HOWL 2021
- Fundamental
- Price
- VNRX $0.64
- HOWL $1.17
- Analyst Decision
- VNRX Strong Buy
- HOWL Strong Buy
- Analyst Count
- VNRX 5
- HOWL 3
- Target Price
- VNRX $3.88
- HOWL $8.33
- AVG Volume (30 Days)
- VNRX 143.7K
- HOWL 263.5K
- Earning Date
- VNRX 08-18-2025
- HOWL 08-15-2025
- Dividend Yield
- VNRX N/A
- HOWL N/A
- EPS Growth
- VNRX N/A
- HOWL N/A
- EPS
- VNRX N/A
- HOWL N/A
- Revenue
- VNRX $1,308,361.00
- HOWL $1,143,000.00
- Revenue This Year
- VNRX $372.23
- HOWL N/A
- Revenue Next Year
- VNRX $201.80
- HOWL N/A
- P/E Ratio
- VNRX N/A
- HOWL N/A
- Revenue Growth
- VNRX 64.16
- HOWL N/A
- 52 Week Low
- VNRX $0.40
- HOWL $0.60
- 52 Week High
- VNRX $0.94
- HOWL $4.18
- Technical
- Relative Strength Index (RSI)
- VNRX 44.71
- HOWL 42.82
- Support Level
- VNRX $0.60
- HOWL $1.15
- Resistance Level
- VNRX $0.80
- HOWL $1.29
- Average True Range (ATR)
- VNRX 0.05
- HOWL 0.09
- MACD
- VNRX -0.01
- HOWL -0.02
- Stochastic Oscillator
- VNRX 21.00
- HOWL 15.87
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.